🇺🇸 Sustanon in United States

80 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 80

Most-reported reactions

1. Drug Abuse — 13 reports (16.25%)
2. Off Label Use — 10 reports (12.5%)
3. Secondary Hypogonadism — 9 reports (11.25%)
4. Diabetes Mellitus — 8 reports (10%)
5. Dyspnoea — 7 reports (8.75%)
6. Fatigue — 7 reports (8.75%)
7. Mood Altered — 7 reports (8.75%)
8. Pyrexia — 7 reports (8.75%)
9. Autoimmune Thyroiditis — 6 reports (7.5%)
10. Malaise — 6 reports (7.5%)

Source database →

Frequently asked questions

Is Sustanon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sustanon in United States?

Gulhane School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.